Journal of Pediatrics Review

Published by: Kowsar

Chronic Inflammatory Demyelinating Polyneuropathy in Children: A Review of Clinical Characteristics and Recommendations for Treatment

Narges Karimi 1 , * , Athena Sharifi 1 , Ashraf Zarvani 1 and Hamed Cheraghmakani 1
Authors Information
1 Department of Neurology, Clinical Research Development Unit of Bou Ali Sina Hospital, Mazandaran University of Medical Sciences, Sari, IR Iran
Article information
  • Journal of Pediatrics Review: July 28, 2015, 3 (2); e2269
  • Published Online: July 20, 2015
  • Article Type: Review Article
  • Received: May 9, 2015
  • Revised: June 10, 2015
  • Accepted: June 20, 2015
  • DOI: 10.17795/jpr-2269

To Cite: Karimi N, Sharifi A, Zarvani A, Cheraghmakani H. Chronic Inflammatory Demyelinating Polyneuropathy in Children: A Review of Clinical Characteristics and Recommendations for Treatment, J Pediatr Rev. 2015 ;3(2):e2269. doi: 10.17795/jpr-2269.

Abstract
Copyright: Copyright © 0, Journal of Pediatrics Review. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Footnotes
References
  • 1. Kalita J, Misra UK, Yadav RK. A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus. Eur J Neurol. 2007; 14(6): 638-43[DOI][PubMed]
  • 2. Markowitz JA, Jeste SS, Kang PB. Child neurology: chronic inflammatory demyelinating polyradiculoneuropathy in children. Neurology. 2008; 71(23)-8[DOI][PubMed]
  • 3. Oh SJ, Kurokawa K, de Almeida DF, Ryan HJ, Claussen GC. Subacute inflammatory demyelinating polyneuropathy. Neurology. 2003; 61(11): 1507-12[PubMed]
  • 4. Burns TM, Dyck PJ, Darras BT, Jones HR. Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach. 2003;
  • 5. Connolly AM. Chronic inflammatory demyelinating polyneuropathy in childhood. Pediatr Neurol. 2001; 24(3): 177-82[DOI]
  • 6. Harbo T, Andersen H, Jakobsen J. Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2008; 38(2): 1036-45[DOI][PubMed]
  • 7. Joint Task Force of the E, the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--First Revision. J Peripher Nerv Syst. 2010; 15(1): 1-9[DOI][PubMed]
  • 8. Hughes R, Bensa S, Willison H, Van den Bergh P, Comi G, Illa I, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 2001; 50(2): 195-201[PubMed]
  • 9. McLeod JG, Pollard JD, Macaskill P, Mohamed A, Spring P, Khurana V. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol. 1999; 46(6): 910-3[PubMed]
  • 10. Iijima M, Koike H, Hattori N, Tamakoshi A, Katsuno M, Tanaka F, et al. Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population. J Neurol Neurosurg Psychiatry. 2008; 79(9): 1040-3[DOI][PubMed]
  • 11. Majumdar A, Hartley L, Manzur AY, King RH, Orrell RW, Muntoni F. A case of severe congenital chronic inflammatory demyelinating polyneuropathy with complete spontaneous remission. Neuromuscul Disord. 2004; 14(12): 818-21[DOI][PubMed]
  • 12. Pearce J, Pitt M, Martinez A. A neonatal diagnosis of congenital chronic inflammatory demyelinating polyneuropathy. Dev Med Child Neurol. 2005; 47(7): 489-92[PubMed]
  • 13. Dalakas MC. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol. 2011; 7(9): 507-17[DOI][PubMed]
  • 14. Sladky JT. Guillain-Barre syndrome in children. J Child Neurol. 2004; 19(3): 191-200[PubMed]
  • 15. Nevo Y, Topaloglu H. 88th ENMC international workshop: childhood chronic inflammatory demyelinating polyneuropathy (including revised diagnostic criteria), Naarden, The Netherlands, December 8-10, 2000. Neuromuscul Disord. 2002; 12(2): 195-200[PubMed]
  • 16. Lewis RA. Chronic inflammatory demyelinating polyneuropathy. Neurol Clin. 2007; 25(1): 71-87[DOI][PubMed]
  • 17. Nevo Y. Childhood chronic inflammatory demyelinating polyneuropathy. Eur J Paediatr Neurol. 1998; 2(4): 169-77[PubMed]
  • 18. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain. 2002; 125: 2591-625[PubMed]
  • 19. Hattori N, Ichimura M, Aoki S, Nagamatsu M, Yasuda T, Kumazawa K, et al. Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood. J Neurol Sci. 1998; 154(1): 66-71[PubMed]
  • 20. Ryan MM, Grattan-Smith PJ, Procopis PG, Morgan G, Ouvrier RA. Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome. Neuromuscul Disord. 2000; 10(6): 398-406[PubMed]
  • 21. Nevo Y, Pestronk A, Kornberg AJ, Connolly AM, Yee WC, Iqbal I, et al. Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up. Neurology. 1996; 47(1): 98-102[PubMed]
  • 22. Sladky JT. What is the best initial treatment for childhood chronic inflammatory demyelinating polyneuropathy: corticosteroids or intravenous immunoglobulin? Muscle Nerve. 2008; 38(6): 1638-43[DOI][PubMed]
  • 23. Polat M, Tosun A, Serdaroglu G, Caglayan E, Karapinar B, Gokben S, et al. Chronic inflammatory demyelinating polyradiculopathy: an atypical pediatric case complicated with phrenic nerve palsy. Turk J Pediatr. 2007; 49(2): 210-4[PubMed]
  • 24. Burns TM. Chronic inflammatory demyelinating polyradiculoneuropathy. Arch Neurol. 2004; 61(6): 973-5[DOI][PubMed]
  • 25. Rossignol E, D'Anjou G, Lapointe N, Haddad E, Vanasse M. Evolution and treatment of childhood chronic inflammatory polyneuropathy. Pediatr Neurol. 2007; 36(2): 88-94[DOI][PubMed]
  • 26. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve. 2001; 24(3): 311-24[PubMed]
  • 27. McDonald DG, Farrell MA, McMenamin JB. Focal upper limb neuropathy in a child. Eur J Paediatr Neurol. 2000; 4(6): 283-7[DOI][PubMed]
  • 28. Jha S, Ansari M, Sonkar K, Paliwal V. Unusual features in chronic inflammatory demyelinating polyneuropathy: Good outcome after prolonged ventilatory support. J Neurosci Rural Pract. 2011; 2(2): 171-3[DOI][PubMed]
  • 29. Kokubun N, Hirata K. Neurophysiological evaluation of trigeminal and facial nerves in patients with chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2007; 35(2): 203-7[DOI][PubMed]
  • 30. Simmons Z, Wald JJ, Albers JW. Chronic inflammatory demyelinating polyradiculoneuropathy in children: I. Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults. Muscle Nerve. 1997; 20(8): 1008-15[PubMed]
  • 31. Luan X, Zheng R, Chen B, Yuan Y. Childhood chronic inflammatory demyelinating polyneuropathy with nonuniform pathologic features. Pediatr Neurol. 2010; 43(2): 103-9[DOI][PubMed]
  • 32. Costello F, Lee AG, Afifi AK, Kelkar P, Kardon RH, White M. Childhood-onset chronic inflammatory demyelinating polyradiculoneuropathy with cranial nerve involvement. J Child Neurol. 2002; 17(11): 819-23[PubMed]
  • 33. Rodriguez-Casero MV, Shield LK, Coleman LT, Kornberg AJ. Childhood chronic inflammatory demyelinating polyneuropathy with central nervous system demyelination resembling multiple sclerosis. Neuromuscul Disord. 2003; 13(2): 158-61[PubMed]
  • 34. Korinthenberg R. Chronic inflammatory demyelinating polyradiculoneuropathy in children and their response to treatment. Neuropediatrics. 1999; 30(4): 190-6[DOI][PubMed]
  • 35. Stojanovic VD, Doronjski AR, Spasojevic SD, Pavlovic VS, Nikolic MM, Kovacevic BB. Chronic inflammatory demyelinating polyradiculoneuropathy, in an 8-year-old girl, complicated by deafness and kidney fibrosis. J Child Neurol. 2009; 24(8): 997-1000[DOI][PubMed]
  • 36. Sladky JT, Brown MJ, Berman PH. Chronic inflammatory demyelinating polyneuropathy of infancy: a corticosteroid-responsive disorder. Ann Neurol. 1986; 20(1): 76-81[DOI][PubMed]
  • 37. Duggins AJ, McLeod JG, Pollard JD, Davies L, Yang F, Thompson EO, et al. Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain. 1999; 122 ( Pt 7): 1383-90[PubMed]
  • 38. Abe Y, Terashima H, Hoshino H, Sassa K, Sakai T, Ohtake A, et al. Characteristic MRI features of chronic inflammatory demyelinating polyradiculoneuropathy. Brain Dev. 2015; [DOI][PubMed]
  • 39. Khadilkar SV, Visana DR, Huchche AM, Shah N, Gupta N, Bharucha NE. Hypertrophic trigeminal nerves: moustache sign. Neurol India. 2013; 61(5): 566-7[DOI][PubMed]
  • 40. Cellerini M, Salti S, Desideri V, Marconi G. MR imaging of the cauda equina in hereditary motor sensory neuropathies: correlations with sural nerve biopsy. AJNR Am J Neuroradiol. 2000; 21(10): 1793-8[PubMed]
  • 41. Yener GG, Guiochon-Mantel A, Obuz F, Baklan B, Ozturk V, Kovanlikaya I, et al. Phe 84 deletion of the PMP22 gene associated with hereditary motor and sensory neuropathy HMSN III with multiple cranial neuropathy: clinical, neurophysiological and magnetic resonance imaging findings. J Neurol. 2001; 248(3): 193-6[PubMed]
  • 42. Aho TR, Wallace RC, Pitt AM, Sivakumar K. Charcot-Marie-Tooth disease: extensive cranial nerve involvement on CT and MR imaging. AJNR Am J Neuroradiol. 2004; 25(3): 494-7[PubMed]
  • 43. Rossi DP, Doria Lamba L, Pistorio A, Pedemonte M, Veneselli E, Rossi A. Chronic inflammatory demyelinating polyneuropathy of childhood: clinical and neuroradiological findings. Neuroradiology. 2013; 55(10): 1233-9[DOI][PubMed]
  • 44. Kararizou E, Karandreas N, Davaki P, Davou R, Vassilopoulos D. Polyneuropathies in teenagers: a clinicopathological study of 45 cases. Neuromuscul Disord. 2006; 16(5): 304-7[DOI][PubMed]
  • 45. Riekhoff AG, Jadoul C, Mercelis R, Cras P, Ceulemans BP. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature. Eur J Paediatr Neurol. 2012; 16(4): 315-31[DOI][PubMed]
  • 46. Köller H, Kieseier BC, Jander S, Hartung HP. Chronic inflammatory demyelinating polyneuropathy. New Engl J Med. 2005; 352(13): 1343-56
  • 47. Eftimov F, Winer JB, Vermeulen M, de Haan R, van Schaik IN. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2009; (1)[DOI][PubMed]
  • 48. Barisic N, Horvath R, Grkovic L, Mihelcic D, Luetic T. Progressive chronic inflammatory demyelinating polyneuropathy in a child with central nervous system involvement and myopathy. Coll Antropol. 2006; 30(4): 945-9[PubMed]
  • 49. Al-Bloushi MAS, Habeeb YK, Al-Jumah ES. Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Two Children. Kuwait Med J. 2009; 41(2): 156-61
  • 50. McMillan HJ, Kang PB, Jones HR, Darras BT. Childhood chronic inflammatory demyelinating polyradiculoneuropathy: combined analysis of a large cohort and eleven published series. Neuromuscul Disord. 2013; 23(2): 103-11[DOI][PubMed]
  • 51. Sivathanu S, Sampath S. Childhood Chronic Inflammatory Demyelinating Polyneuropathy – A Report of Two Cases. Brain Disord Ther. 2015; 4(1): 1-3
  • 52. Brannagan T3. Current treatments of chronic immune-mediated demyelinating polyneuropathies. Muscle Nerve. 2009; 39(5): 563-78[DOI][PubMed]
  • 53. Grillo JA, Gorson KC, Ropper AH, Lewis J, Weinstein R. Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders. Neurology. 2001; 57(9): 1699-701[PubMed]
  • 54. Fudge E, Carol J, She JX, Dosch M, Atkinson M, Muir A. Chronic inflammatory demyelinating polyradiculoneuropathy in two children with type 1 diabetes mellitus. Pediatr Diabetes. 2005; 6(4): 244-8[DOI][PubMed]
  • 55. Sander HW, Hedley-Whyte ET. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-2003. A nine-year-old girl with progressive weakness and areflexia. N Engl J Med. 2003; 348(8): 735-43[DOI][PubMed]
  • 56. Valenzise M, Meloni A, Betterle C, Giometto B, Autunno M, Mazzeo A, et al. Chronic inflammatory demyelinating polyneuropathy as a possible novel component of autoimmune poly-endocrine-candidiasis-ectodermal dystrophy. Eur J Pediatr. 2009; 168(2): 237-40[DOI][PubMed]
  • 57. Mohamed AR, Rodriguez-Casero MV, Ryan MM. Atypical childhood chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2010; 42(2): 293-5[DOI][PubMed]
  • 58. Rostasy KM, Diepold K, Buckard J, Brockmann K, Wilken B, Hanefeld F. Progressive muscle weakness after high-dose steroids in two children with CIDP. Pediatr Neurol. 2003; 29(3): 236-8[PubMed]
  • 59. McMillan HJ, Darras BT, Kang PB. Autoimmune neuromuscular disorders in childhood. Curr Treat Options Neurol. 2011; 13(6): 590-607[DOI][PubMed]
  • 60. Walk D, Li LY, Parry GJ, Day JW. Rapid resolution of quadriplegic CIDP by combined plasmapheresis and IVIg. Neurology. 2004; 62(1): 155-6[PubMed]
  • 61. Gorson KC. An update on the management of chronic inflammatory demyelinating polyneuropathy. Ther Adv Neurol Disord. 2012; 5(6): 359-73[DOI][PubMed]
  • 62. Ropper AH. Current treatments for CIDP. Neurol. 2003; 60(8 suppl 3)-22
  • 63. Rabie M, Nevo Y. Childhood acute and chronic immune-mediated polyradiculoneuropathies. Eur J Paediatr Neurol. 2009; 13(3): 209-18[DOI][PubMed]
  • 64. Said G. Chronic inflammatory demyelinating polyneuropathy. Neuromuscul Disord. 2006; 16(5): 293-303[DOI][PubMed]
  • 65. Sabatelli M, Madia F, Mignogna T, Lippi G, Quaranta L, Tonali P. Pure motor chronic inflammatory demyelinating polyneuropathy. J Neurol. 2001; 248(9): 772-7[PubMed]
  • 66. Hahn AF, Bolton CF, Pillay N, Chalk C, Benstead T, Bril V, et al. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. Brain. 1996; 119 ( Pt 4): 1055-66[PubMed]
  • 67. Dyck PJ, Litchy WJ, Kratz KM, Suarez GA, Low PA, Pineda AA, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 1994; 36(6): 838-45[DOI][PubMed]
  • 68. Berger AR, Herskovitz S, Scelsa S. The restoration of IVIg efficacy by plasma exchange in CIDP. Neurology. 1995; 45(8): 1628-9[PubMed]
  • 69. Marsh EA, Hirst CL, Llewelyn JG, Cossburn MD, Reilly MM, Krishnan A, et al. Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy. J Neurol. 2010; 257(6): 913-9[DOI][PubMed]
  • 70. Visudtibhan A, Chiemchanya S, Visudhiphan P. Cyclosporine in chronic inflammatory demyelinating polyradiculoneuropathy. Pediatr Neurol. 2005; 33(5): 368-72[DOI][PubMed]
  • 71. Hadden RD, Hughes RA. Management of inflammatory neuropathies. J Neurol Neurosurg Psychiatry. 2003; 74 Suppl 2[PubMed]
  • 72. Gono T, Matsuda M, Shimojima Y, Ishii W, Yamamoto K, Morita H, et al. Rituximab therapy in chronic inflammatory demyelinating polyradiculoneuropathy with anti-SGPG IgM antibody. J Clin Neurosci. 2006; 13(6): 683-7[DOI][PubMed]
  • 73. Munch C, Anagnostou P, Meyer R, Haas J. Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus. J Neurol Sci. 2007; 256(1-2): 100-2[DOI][PubMed]
  • 74. Hirst C, Raasch S, Llewelyn G, Robertson N. Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H). J Neurol Neurosurg Psychiatry. 2006; 77(6): 800-2[DOI][PubMed]
  • 75. D'Amico A, Catteruccia M, De Benedetti F, Vivarelli M, Colucci M, Cascioli S, et al. Rituximab in a childhood-onset idiopathic refractory chronic inflammatory demyelinating polyneuropathy. Eur J Paediatr Neurol. 2012; 16(3): 301-3[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader